exophthalmos 发表于 2025-3-23 12:49:40

http://reply.papertrans.cn/1/48/4776/4776-11.png

拒绝 发表于 2025-3-23 15:07:25

Submitted on: 15 August 2017.
Revised on: 21 October 2017.
Accepted on: 13 November 2017.

___________________CARDIOVASCULAR DRUGS AND THERAPY

inspiration 发表于 2025-3-23 19:51:20

Submitted on: 07 June 2008.
Revised on: 29 July 2008.
Accepted on: 11 August 2008.

___________________CARDIOVASCULAR DRUGS AND THERAPY

Expiration 发表于 2025-3-24 01:52:05

http://reply.papertrans.cn/1/48/4776/4776-14.png

subacute 发表于 2025-3-24 04:22:54

http://reply.papertrans.cn/1/48/4776/4776-15.png

Decibel 发表于 2025-3-24 10:10:28

http://reply.papertrans.cn/1/48/4776/4776-16.png

群岛 发表于 2025-3-24 12:45:38

http://reply.papertrans.cn/1/48/4776/4776-17.png

Spongy-Bone 发表于 2025-3-24 17:15:44

http://reply.papertrans.cn/1/48/4776/4776-18.png

最高峰 发表于 2025-3-24 21:47:04

http://reply.papertrans.cn/1/48/4776/4776-19.png

Encephalitis 发表于 2025-3-25 01:44:36

Submitted on: 21 March 2016.
Revised on: 02 May 2016.
Accepted on: 27 June 2016.

___________________CARDIOVASCULAR DRUGS AND THERAPY
页: 1 [2] 3 4
查看完整版本: SCIE期刊CARDIOVASCULAR DRUGS AND THERAPY 2024/2025影响因子:3.146 (CARDIOVASC DRUG THER) (0920-3206). (CARDIAC & CARDIOVASCULA